Ziyi Yang1,2, Tai Ren2,3, Shilei Liu1,2, Chen Cai1,2, Wei Gong1,2, Yijun Shu1,2. 1. Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. 2. Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China. 3. Ministry of Education - Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Abstract
BACKGROUND: Coagulation and fibrinolysis activation are frequently observed in cancer patients, and the tumors in these cases are thought to be associated with a higher risk of invasion, metastasis and worse long-term outcome. The specific aim of this study was to develop an effective prognostic nomogram to help make individualized estimates for patients with resected gallbladder cancer (GBC). METHODS: Patients with resected GBC who were diagnosed between 2006 and 2014 at Xinhua Hospital were selected. Model performance was measured by c-index and calibration curve. The results were further validated using bootstrap and a cohort of 38 patients from a branch hospital who underwent surgery from 2006 to 2014. RESULTS: Backward stepwise selection and Lasso were applied respectively to select predictors. T stage, N stage, and preoperative serum fibrinogen were included in the final model. Predictions correlated well with observed 1- and 3-year survival. The c-index for predicting survival was 0.74 (95% confidence interval, 0.70-0.78), which was statistically higher than that of the AJCC 7th system and Nevin system (P=0.04, 0.04, respectively). In the validation cohort, the nomogram performed better than the other two staging systems (c-index: 0.71 vs. 0.67 and 0.67). CONCLUSIONS: The validated nomogram is a practical tool for predicting the overall survival (OS) of postoperative GBC patients. Preoperative serum fibrinogen levels were associated with tumor progression and may be an independent predictor for GBC patients. 2021 Journal of Gastrointestinal Oncology. All rights reserved.
BACKGROUND: Coagulation and fibrinolysis activation are frequently observed in cancer patients, and the tumors in these cases are thought to be associated with a higher risk of invasion, metastasis and worse long-term outcome. The specific aim of this study was to develop an effective prognostic nomogram to help make individualized estimates for patients with resected gallbladder cancer (GBC). METHODS: Patients with resected GBC who were diagnosed between 2006 and 2014 at Xinhua Hospital were selected. Model performance was measured by c-index and calibration curve. The results were further validated using bootstrap and a cohort of 38 patients from a branch hospital who underwent surgery from 2006 to 2014. RESULTS: Backward stepwise selection and Lasso were applied respectively to select predictors. T stage, N stage, and preoperative serum fibrinogen were included in the final model. Predictions correlated well with observed 1- and 3-year survival. The c-index for predicting survival was 0.74 (95% confidence interval, 0.70-0.78), which was statistically higher than that of the AJCC 7th system and Nevin system (P=0.04, 0.04, respectively). In the validation cohort, the nomogram performed better than the other two staging systems (c-index: 0.71 vs. 0.67 and 0.67). CONCLUSIONS: The validated nomogram is a practical tool for predicting the overall survival (OS) of postoperative GBC patients. Preoperative serum fibrinogen levels were associated with tumor progression and may be an independent predictor for GBC patients. 2021 Journal of Gastrointestinal Oncology. All rights reserved.
Entities:
Keywords:
Clinical prediction model; fibrinogen; gallbladder cancer (GBC); nomogram
Authors: Hiromichi Ito; Kaori Ito; Michael D'Angelica; Mithat Gonen; David Klimstra; Peter Allen; Ronald P DeMatteo; Yuman Fong; Leslie H Blumgart; William R Jarnagin Journal: Ann Surg Date: 2011-08 Impact factor: 12.969
Authors: Tak Geun Oh; Moon Jae Chung; Seungmin Bang; Seung Woo Park; Jae Bok Chung; Si Young Song; Gi Hong Choi; Kyung Sik Kim; Woo Jung Lee; Jeong Youp Park Journal: J Gastrointest Surg Date: 2013-01-09 Impact factor: 3.452
Authors: Vaclav Liska; Vladislav Treska; Tomas Skalicky; Jakub Fichtl; Jan Bruha; Ondrej Vycital; Ondrej Topolcan; Richard Palek; Jachym Rosendorf; Jiri Polivka; Lubos Holubec Journal: Anticancer Res Date: 2017-04 Impact factor: 2.480
Authors: Rahul D Tendulkar; Shree Agrawal; Tianming Gao; Jason A Efstathiou; Thomas M Pisansky; Jeff M Michalski; Bridget F Koontz; Daniel A Hamstra; Felix Y Feng; Stanley L Liauw; Matthew C Abramowitz; Alan Pollack; Mitchell S Anscher; Drew Moghanaki; Robert B Den; Kevin L Stephans; Anthony L Zietman; W Robert Lee; Michael W Kattan; Andrew J Stephenson Journal: J Clin Oncol Date: 2016-10-20 Impact factor: 44.544
Authors: V Seebacher; S Polterauer; C Grimm; H Husslein; H Leipold; K Hefler-Frischmuth; C Tempfer; A Reinthaller; L Hefler Journal: Br J Cancer Date: 2010-02-16 Impact factor: 7.640
Authors: Silvia Guglietta; Andrea Chiavelli; Elena Zagato; Carsten Krieg; Sara Gandini; Paola Simona Ravenda; Barbara Bazolli; Bao Lu; Giuseppe Penna; Maria Rescigno Journal: Nat Commun Date: 2016-03-21 Impact factor: 14.919